Aston University Researchers Collaborate with Biotechnology Start-Up to Develop Drugs to Tackle Irreversible Lung Disease

Aston University announced that they are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as lung disease.